Profound Medical
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $2,483 | $5,263 | $5,977 | $5,289 |
Gross Profit | 1,947 | 3,778 | 3,991 | 3,931 |
EBITDA | -9,350 | -7,811 | -7,260 | -8,766 |
EBIT | -9,485 | -7,909 | -7,369 | -8,913 |
Net Income | -9,540 | -6,955 | -8,175 | -7,977 |
Net Change In Cash | 2,483 | 5,263 | 5,977 | 5,289 |
Free Cash Flow | -11,338 | -8,583 | -6,837 | -9,614 |
Cash | 38,271 | 50,460 | 81,798 | 24,826 |
Basic Shares | 36,350 | 36,297 | 30,726 | 30,104 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $16,379 | $10,167 | $7,199 | $6,681 |
Gross Profit | 11,592 | 6,699 | 4,382 | 3,021 |
EBITDA | -41,406 | -25,591 | -26,781 | -26,604 |
EBIT | -41,976 | -26,482 | -27,927 | -28,208 |
Net Income | -43,315 | -26,480 | -28,569 | -28,669 |
Net Change In Cash | 16,379 | 10,167 | 7,199 | 6,681 |
Free Cash Flow | -39,054 | -23,453 | -22,609 | -25,800 |
Cash | 81,798 | 54,912 | 26,213 | 46,517 |
Basic Shares | 30,232 | 24,765 | 21,182 | 20,829 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.26 |
2026-03-31 | -$0.19 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.26 |